Latest News for: Melbourne patent

Edit

Section III Tri-Valley League boys lacrosse stats leaders (through May 1)

The Post-Standard 02 May 2024
Updated. May. 02, 2024, 10.30 a.m ... Contributing photographer. By Pat Spadafore ... Kyle Erway Holland Patent 13 ... Kyle Erway Holland Patent 11 ... Trenton Stockhauser Holland Patent 59 37 ... Melbourne Sann Holland Patent 21 ... Mason Robenski Holland Patent 12 ... ....
Edit

Alterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 ...

The Eagle-Tribune 20 Feb 2024
MELBOURNE, Australia and SAN FRANCISCO, Feb ... Alterity also has a broad drug discovery platform generating patentable chemical compounds to treat the underlying pathology of neurological diseases.
Edit

Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as ...

Enid News & Eagle 06 Feb 2024
MELBOURNE, AUSTRALIA AND SAN FRANCISCO, Feb ... Alterity also has a broad drug discovery platform generating patentable chemical compounds to intercede in disease processes. The Company is based in Melbourne, Australia, and San Francisco, California, USA.
Edit

Alterity Therapeutics to Participate in the ShareCafe Hidden Gems Webinar This Week

Enid News & Eagle 29 Jan 2024
MELBOURNE, Australia and SAN FRANCISCO, Jan ... Alterity also has a broad drug discovery platform generating patentable chemical compounds to intercede in disease processes. The Company is based in Melbourne, Australia, and San Francisco, California, USA.
Edit

Alterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming ...

Enid News & Eagle 22 Jan 2024
MELBOURNE, Australia and SAN FRANCISCO, Jan ... Alterity also has a broad drug discovery platform generating patentable chemical compounds to treat the underlying pathology of neurological diseases.
Edit

Alterity Therapeutics Appoints Phillip Hains as Chief Financial Officer

Enid News & Eagle 21 Dec 2023
MELBOURNE, Australia and SAN FRANCISCO, Dec ... Alterity also has a broad drug discovery platform generating patentable chemical compounds to treat the underlying pathology of neurological diseases.
Edit

Alterity Therapeutics to Host Webcast to Discuss ATH434 Efficacy Data in Primates and Recent ...

Enid News & Eagle 04 Dec 2023
MELBOURNE, Australia and SAN FRANCISCO, Dec ... AEDT (Sydney/Melbourne) ... Alterity also has a broad drug discovery platform generating patentable chemical compounds to treat the underlying pathology of neurological diseases.
Edit

Alterity Therapeutics Reports Positive Efficacy Data for ATH434 in a Primate Model of ...

Enid News & Eagle 04 Dec 2023
MELBOURNE, Australia and SAN FRANCISCO, Dec ... Alterity also has a broad drug discovery platform generating patentable chemical compounds to treat the underlying pathology of neurological diseases.
Edit

Gift alert: Backstreet Boy Howie D. endorses to this Brevard-created knife sharpener

Florida Today 24 Nov 2023
Angle Pro 2 will ensure you'll never deal with another dull knife ... Rob Landers and Suzy Fleming Leonard, Florida Today ... Borton concurs ... The founder of Rhineland Cutlery, the Melbourne resident has more than 15 knife design patents to his name.
Edit

Alterity Therapeutics Completes Enrolment in ATH434-201 Phase 2 Clinical Trial in Multiple ...

The Eagle-Tribune 08 Nov 2023
MELBOURNE, Australia and SAN FRANCISCO, Nov ... Alterity also has a broad drug discovery platform generating patentable chemical compounds to treat the underlying pathology of neurological diseases.
Edit

Appendix 4C – Q1 FY24 Quarterly Cash Flow Report

The Eagle-Tribune 30 Oct 2023
MELBOURNE, Australia and SAN FRANCISCO, Oct ... Composition of Matter Patent Granted in Europe. The European Patent Office granted Alterity a new composition of matter patent. The patent secures broad ...
Edit

Alterity Therapeutics Presents New Data on Multiple System Atrophy, a Rare Parkinsonian Disorder

Enid News & Eagle 31 Aug 2023
MELBOURNE, Australia and SAN FRANCISCO, Aug ... Alterity also has a broad drug discovery platform generating patentable chemical compounds to treat the underlying pathology of neurological diseases.
Edit

Alterity Therapeutics Granted New Composition of Matter Patent in Europe for Neurodegenerative ...

Eagle-Tribune 23 Aug 2023
MELBOURNE, Australia and SAN FRANCISCO, Aug ... of matter patent. The patent secures broad protection over a new class of iron chaperone drug candidates for treating major neurodegenerative diseases.
Edit

Alterity Therapeutics Rare Disease Natural History Study to be Featured at the International ...

Enid News & Eagle 22 Aug 2023
MELBOURNE, Australia and SAN FRANCISCO, Aug ... Alterity also has a broad drug discovery platform generating patentable chemical compounds to treat the underlying pathology of neurological diseases.
Edit

Alterity Therapeutics Receives a $4.74 million Research & Development Tax Incentive Refund

Eagle-Tribune 15 Aug 2023
MELBOURNE, Australia and SAN FRANCISCO, Aug ... Alterity also has a broad drug discovery platform generating patentable chemical compounds to treat the underlying pathology of neurological diseases.
×